EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
Active Implantable Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 24 April 2024. Database contains 4753 unique substances/entries.
Filter the list
|
The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).
|
309-745-9
|
100801-63-6
|
Carc. 1B; Muta. 1B |
||
|
233-113-0
|
10035-10-6
|
Press. Gas; Skin Corr. 1A; STOT SE 3 |
|||
|
233-113-0
|
10035-10-6
|
Skin Corr. 1B; STOT SE 3 |
|||
|
233-109-9
|
10034-85-2
|
Press. Gas; Skin Corr. 1A |
|||
|
233-109-9
|
10034-85-2
|
Skin Corr. 1B |
|||
|
204-563-5
|
122-66-7
|
Carc. 1B; Acute Tox. 4 |
|||
|
HNF; HYDRAZINIUM NITROFORMATE
|
414-850-9
|
4682-01-3
|
Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
||
|
616-584-0
|
7803-57-8
|
yes |
|||
|
STABO-FIX
|
405-030-1
|
148434-03-1
|
Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
||
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
yes |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
Acute Tox. 4; Eye Dam. 1 |
||
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
Skin Sens. 1 |
||
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
Resp. Sens. 1; Skin Sens. 1 |
||
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
Eye Dam. 1 |
||
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
Eye Irrit. 2 |
||
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
Eye Dam. 1; Skin Sens. 1 |
||
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
|||
|
-
|
-
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-523-4
|
107-83-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-731-1
|
591-78-6
|
Flam. Liq. 3; Repr. 2; STOT RE 1; STOT SE 3 |
|||
|
203-852-3
|
111-27-3
|
Acute Tox. 4 |
|||
|
211-653-8
|
680-31-9
|
Carc. 1B; Muta. 1B |
|||
|
204-679-6
|
124-09-4
|
Acute Tox. 4; STOT SE 3; Skin Corr. 1B |
|||
|
212-485-8
|
822-06-0
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
235-921-9
|
13048-33-4
|
Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
Acute Tox. 3; Skin Sens. 1 |
||
|
247-094-1
|
25550-51-0
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
||
|
243-072-0
|
19438-60-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
|||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
Acute Tox. 4; Skin Sens. 1 |
||
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
|||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
|
-
|
-
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
|||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
|||
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
|||